ResMed: Result 2016
Margins are down again for this maker of sleep apnea products, and we're getting impatient.
IOOF steadies the ship
The consolidation of its platforms and a decent fund flow performance in the June quarter have taken some of the risk out of this wealth manager.
Primary works on image problem
Primary Health Care's least talked about division has some bright spots on the horizon, and it's helping to improve the balance sheet.
iCar Asia: receipts fall short
Revenues are growing more slowly than the market hoped, and the risks of another capital raising have jumped.
Woolworths takes a big bath
More writedowns will hit the 2016 result, but underlying earnings are within expectations and there's early evidence customers are returning.
AFIC: turning a big ship
AFIC's results highlighted a growing exposure to medium sized and smaller companies
SomnoMed Q4 sales up 29%
SomnoMed achieved another quarter of strong growth with insurance reimbursement issues subsiding.
Coca-Cola Amatil's Big headache
Greater competition at home and abroad is a bad sign. Coca-Cola Amatil's market share is set to decline further.
Tatts: The lottery that always pays?
Tatts has a monopoly on Australian lotteries, but will its wagering business bring it down?
SomnoMed gets a new chief
SomnoMed has recruited a new chief executive to build the business in the USA.
Runge pivots from mining to software
RungePincockMinarco was crushed by the end of the mining boom. But a dramatic shift in emphasis is changing this business very much for the better.
Fleetwood downgraded
The situation is getting better but the improvements are now reflected in Fleetwood's share price.
Viva switches to premium
This owner of 425 Coles-Shell petrol stations is taking advantage of rising property prices to become Australia's first listed property trust that owns petrol stations.
South32: CrapCo no more
Quality assets and sensible management should deliver South32's first dividend.
Sirtex: The value of innovation
As sales of Sirtex's flagship product continue to grow, what's next in the R&D pipeline?
Is Kogan on sale?
With a share price that's fallen 16% since last week's IPO, Andrew Legget runs the ruler over this highly efficient, growing online retailer.
Ainsworth's share price fall
The company's share price has fallen by 15% since shareholders approved the Novomatic transaction last week
Intecq powers along
Once featured in a special report on small stocks, we take another look at Intecq (FKA eBET).
News Corp's leap of faith
It's difficult to find a company less loved than News Corp. But every way we dice it, the value looks compelling.
Call 1300 880 160
Start a chat
Schedule a call
